NEWS AND EVENTS

The agreement between Switzerland and the European Union EU) on mutual recognition in relation to co...

EMA will organise an online walk-in clinic on CTIS on 28.3.2022, 16:00-17:00 CEST ...

EMA updates guidance in forms of questions and answers (Q&A) on Good manufacturing practice / Good d...

Environment and sustainability questions are becoming common for all industry sectors, thus healthca...

The new data raised concerns from a toxicological point of view.

Due to the Brexit, the EU Clinical Trial Regulation is not (directly) applicable in UK....

Revised guidance relating to Clinical Trials during the COVID-19 Pandemic. ...

Rules for electronic instructions for use for medical devices.

New EU rules for safe and high-quality medicines for animals.

IPEC’s position on the role of excipients when conducting nitrosamine risk assessments for drug pr...

Concept Paper on the revision of guideline on Good agricultural and collection practice (GACP) for s...

PIC/S has updated its GMP guide, aligning it with EU requirements to promote harmonization....

What is foreseen for medicines containing Titanium dioxide (E171)?

US FDA formally proposes aligning Quality System Regulations with ISO 13485 - another step forward t...

EMA Guidelines on the requirements for quality documentation concerning medicinal products in clinic...

Currently in the EU only national pharmacopoeia monographs are available for Cannabis Flower and Can...